Functional Unit for Breast and Soft Tissue Tumors, Instituto Nacional de Cancerología, Bogotá 111511, Colombia.
Fundación Universitaria de Ciencias de la Salud, Bogotá 111411, Colombia.
Curr Oncol. 2024 Mar 26;31(4):1725-1738. doi: 10.3390/curroncol31040131.
Soft tissue sarcomas (STS) are low-incidence tumors whose clinical and histopathological factors are associated with adverse oncological outcomes. This study evaluated prognostic factors (PF) associated with tumor recurrence and overall survival (OS) in patients diagnosed with STS of the extremities, treated at the Instituto Nacional de Cancerología (INC), Bogotá, Colombia. An analytical observational study of a historical cohort was carried out, including patients diagnosed with STS and managed surgically in the Functional Unit for Breast and Soft Tissue Tumors of the INC from January 2008 to December 2018. A total of 227 patients were included; 74.5% had tumors greater than 5 cm. Most patients (29.1%) were in stage IIIB at diagnosis. Age was associated with higher mortality (HR = 1.01; CI95%: 1-1.02; = 0.048). Tumor persistence at admission to the INC (HR = 2.34; CI95%: 1.25-4.35; = 0.007) and histologic grade III (HR = 5.36; CI95%: 2.29-12.56; = <0.001) showed statistical significance in the multivariate analysis for recurrence of any type, as did the PFs associated with a higher risk of local recurrence (HR = 2.85; CI95%: 1.23-6.57; = 0.014 and HR = 6.09; CI95%: 2.03-18.2; = 0.001), respectively. Tumor size (HR = 1.03; CI95%: 1-1.06; = 0.015) and histologic grade III (HR = 4.53; CI95%: 1.42-14.49; = 0.011) were associated with a higher risk of distant recurrence. This cohort showed that in addition to histologic grade and tumor size, tumor persistence at the time of admission has an impact on disease recurrence, so STS should be managed by a multidisciplinary team with experience in this pathology in high-volume reference centers.
软组织肉瘤(STS)是一种发病率较低的肿瘤,其临床和组织病理学因素与不良的肿瘤学结局相关。本研究评估了与在哥伦比亚波哥大国家癌症研究所(INC)接受治疗的四肢软组织肉瘤患者的肿瘤复发和总生存(OS)相关的预后因素(PF)。这是一项对历史队列进行的分析性观察研究,纳入了 2008 年 1 月至 2018 年 12 月在 INC 的乳腺和软组织肿瘤功能单位接受手术治疗的 STS 患者。共纳入 227 例患者;74.5%的肿瘤大于 5cm。大多数患者(29.1%)在诊断时处于 IIIB 期。年龄与死亡率升高相关(HR=1.01;95%CI:1-1.02; = 0.048)。INC 入院时肿瘤持续存在(HR=2.34;95%CI:1.25-4.35; = 0.007)和组织学分级 III 级(HR=5.36;95%CI:2.29-12.56; = <0.001)在多变量分析中显示与任何类型的复发均具有统计学意义,与局部复发风险较高相关的 PF 也如此(HR=2.85;95%CI:1.23-6.57; = 0.014 和 HR=6.09;95%CI:2.03-18.2; = 0.001)。肿瘤大小(HR=1.03;95%CI:1-1.06; = 0.015)和组织学分级 III 级(HR=4.53;95%CI:1.42-14.49; = 0.011)与远处复发风险增加相关。该队列表明,除了组织学分级和肿瘤大小外,入院时肿瘤持续存在对疾病复发有影响,因此 STS 应由具有该病理学经验的多学科团队在高容量的参考中心进行管理。